Tikun Olam Cannbit Pharmaceuticals Overview
- Status
-
Public
- Employees
-
4
- Stock Symbol
-
TKUN-M
- Investments
-
1
- Share Price
-
$507.02
- (As of Friday Closing)
Tikun Olam Cannbit Pharmaceuticals General Information
Description
Tikun Olam Cannbit Pharmaceuticals Ltd is engaged in the business of growing and marketing medical cannabis.
Contact Information
Website
cannbit.comCorporate Office
- Hashla 9
- Tel Aviv
- Israel
Corporate Office
- Hashla 9
- Tel Aviv
- Israel
Tikun Olam Cannbit Pharmaceuticals Stock Performance
As of 13-Nov-2026, Tikun Olam Cannbit Pharmaceuticals’s stock price is $507.02. Its current market cap is $861K with 1.7K shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $507.02 | $434.66 | $150.55 - $5.69K | $861K | 1.7K | 18.44 | $1.14M |
Tikun Olam Cannbit Pharmaceuticals Financials Summary
As of 30-Jun-2026, Tikun Olam Cannbit Pharmaceuticals has a trailing 12-month revenue of $331K.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,579 | 8,564 | 9,607 | 10,925 |
| Revenue | 331 | 2,620 | 9,373 | 11,938 |
| EBITDA | (808) | (637) | (2,310) | (8,902) |
| Net Income | (1,080) | (4,563) | (10,754) | (23,991) |
| Total Assets | 487 | 471 | 6,572 | 20,170 |
| Total Debt | 3,910 | 3,708 | 4,448 | 5,285 |
Tikun Olam Cannbit Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tikun Olam Cannbit Pharmaceuticals Signals
Tikun Olam Cannbit Pharmaceuticals Acquisitions (1)
Tikun Olam Cannbit Pharmaceuticals’s most recent deal was a Merger/Acquisition with Tikun Olam for . The deal was made on 25-Nov-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Tikun Olam | 25-Nov-2019 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Tikun Olam Cannbit Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Food Products
Industry
Rank
Percentile
Agriculture
Subindustry
Rank
Percentile
Tikun Olam Cannbit Pharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Tikun Olam | Tel Aviv, Israel | 2006 |
Tikun Olam Cannbit Pharmaceuticals FAQs
-
Where is Tikun Olam Cannbit Pharmaceuticals headquartered?
Tikun Olam Cannbit Pharmaceuticals is headquartered in Tel Aviv, Israel.
-
What is the size of Tikun Olam Cannbit Pharmaceuticals?
Tikun Olam Cannbit Pharmaceuticals has 4 total employees.
-
What industry is Tikun Olam Cannbit Pharmaceuticals in?
Tikun Olam Cannbit Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Tikun Olam Cannbit Pharmaceuticals a private or public company?
Tikun Olam Cannbit Pharmaceuticals is a Public company.
-
What is Tikun Olam Cannbit Pharmaceuticals’s stock symbol?
The ticker symbol for Tikun Olam Cannbit Pharmaceuticals is TKUN-M.
-
What is the current stock price of Tikun Olam Cannbit Pharmaceuticals?
As of 13-Nov-2026 the stock price of Tikun Olam Cannbit Pharmaceuticals is $507.02.
-
What is the current market cap of Tikun Olam Cannbit Pharmaceuticals?
The current market capitalization of Tikun Olam Cannbit Pharmaceuticals is $861K.
-
What is Tikun Olam Cannbit Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Tikun Olam Cannbit Pharmaceuticals is $331K.
-
What is Tikun Olam Cannbit Pharmaceuticals’s annual earnings per share (EPS)?
Tikun Olam Cannbit Pharmaceuticals’s EPS for 12 months was $1.14M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process